Best in 7 days
Pay in installments of $11.50 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jun 14 - Jun 19
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
NexGard COMBO spot-on CAT x 3X0.3ML // Esafoxolaner+ Eprinomectin+ PraziquantelDescription: NexGard Combo spot on solution for cats < 2. 5 kg NexGard Combo spot on solution for cats 2. 5 7. 5 kg 1. NAME AND ADDRESS OF THE MARKETING AUTHORIZATION HOLDER AND THE MANUFACTURING AUTHORIZATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT Marketing Authorization Holder: Boehringer Ingelheim Vetmedica GmbH 55216 Ingelheim Rhein Germany Manufacturer responsible for batch release: Boehringer Ingelheim Animal Health France SCS 4
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
Discover Niche Categories That Outsell
Top-Converting Item to Boost Your Average Order
Best in 7 days
Best in 7 days
Best in 7 days
Best in 7 days
4.2 ★★★★★
Based on 2275 reviews
Sort
Product Reviews
★★★★★ 3
Didn’t live up to the hype.
I had high hopes for this product. I’ve seen it all over social, but for me it didn’t live up to the hype. Although it is very moisturizing, it never dries down. There’s no way I could apply makeup over this, as the ads might lead you to believe. If you want a good night time moisturizer then this product is for you.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 13, 2026
★★★★★ 1
No Good
So I got this under the impression by the videos online that this was really concealing under the eye and it’s not…very oily and hasn’t done anything for under my eyes at all! Scam!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 8, 2026
★★★★★ 5
Great product!
Love this product. Lightweight and feels great on the skin.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 7, 2026
★★★★★ 5
Pleasantly surprised
I’m two jars in and love it. I do use Botox, retinol, a good face wash, wash moisturize twice daily, etc etc. I struggle with moisturizer because I’m prone to breakouts. Idk what it is about this one but my skin loves it. It feels refreshed and soft. Added bonus, my eyebrows and lashes have gotten longer and darker quick! Obviously we all respond differently to products but I’ll be keeping this in my rotation
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 3, 2026
★★★★★ 5
A thick and rich cream that smooths on nicely!
So I jumped on the Korean skincare bandwagon and decided to purchase some of the DR MELAXIN Products to try! I read many good reviews and decided it was worth the money. This first product is the Dr Melaxin Calcium cemenrete calcium volume cream. It comes in a 1.76 ounce glass jar. On the label there is a lot of word descriptions so I will add a few: Ex volume firming, rebornic 10,000 ppm hydrolyzed elastin and collagen extract. I have photographed label for viewing. The directions indicate to "apply a small amount of cream onto your face especially around the under-eye area". I found the cream thick and rich and I used it in addition to another Dr Melaxin neck and face product so I concentrated on only neck and under eye area. It is neutral in scent and is very thick so it feels like it is absorbing nicely. I have been using it for about a month now and have definitely noticed some improvement in the neck area so i will continue to use and layer with other products. I do recommend this line as the ingredients seem effective so far!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 4, 2026
